Supply chain disruptions are increasingly threatening the safe and timely delivery of essential pharmaceuticals. Delays, rising costs, and product spoilage can put patient care and business continuity at risk. This whitepaper reveals proven strategies to build resilience and future-proof pharma supply chains. Drawing on expertise from DP World and insights from industry leaders such as Merck, Deloitte, and McKinsey, this asset is grounded in real-world experience and trusted research. In this whitepaper, you'll learn how to:

Data decisions made at each step of the drug development process – from target identification and discovery right through to final recipes in manufacturing – have an impact on time-to-market. In pharmaceuticals, as in most industries, time is money, so any aspect that can be modified to shorten the time taken at any step will bring about cost efficiencies. At a recent online roundtable event, hosted by Scientific Computing World, representatives from the entire development process exchanged thoughts and ideas on considerations and improvements that could be made to data collection, storage, retrieval and analysis.